Abstract

L Noimark, J Wales, G Du Toit. Clin Exp Allergy. 2011;42(2):284–292 To evaluate the rate at which adrenaline autoinjectors are used during anaphylactic reactions by patients who have had them prescribed, and to assess the number of devices used for each reaction. Participants ( N = 969) were children and teenagers aged 18 years or less who had been prescribed an adrenaline autoinjector for at least 1 year, recruited from 14 pediatric allergy clinics throughout the United Kingdom. The mean age of participants was 8 years, and approximately half had coexistent asthma. Subjects had been given an allergy management …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call